WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Decades after a US butterfly species vanished, a close relative is released to fill gapPhoto exhibition in Macao displays ancient civilization in ShanghaiAll Blacks center Jordie Barrett joining Leinster in DecemberBuffalo, New York: Remains of missing 12China activates LevelRoyals catcher Salvador Perez sidelined by mild groin strainIAEA warns that attacks on a nuclear plant in RussianCaitlin Clark selected with No. 1 in the WNBA draft by the Indiana FeverNew rules to help improve flow of dataJohn Sterling retires from Yankees broadcast booth at age 85 a few weeks into 34th season
2.5006s , 6497.7578125 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Global Grid news portal